Zynteglo

Bluebird bio lays off staffers in Europe as Zynteglo rollout hits an early reimbursement snag
Bluebird bio lays off staffers in Europe as Zynteglo rollout hits an early reimbursement snag
Fierce Pharma
Bluebird Bio
Zynteglo
reimbursement
layoffs
Germany
gene therapy
Flag link:
EMA begins safety review of bluebird gene therapy following AML case in related therapy
EMA begins safety review of bluebird gene therapy following AML case in related therapy
Endpoints
Bluebird Bio
Zynteglo
Europe
EMA
AML
Flag link:
Bluebird’s Zynteglo safety snag could spell trouble for other gene therapies: analysts
Bluebird’s Zynteglo safety snag could spell trouble for other gene therapies: analysts
Fierce Pharma
gene therapy
Bluebird Bio
Zynteglo
clinical trials
Flag link:
Bluebird gets European green light for gene therapy production
Bluebird gets European green light for gene therapy production
Biopharma Dive
Bluebird Bio
gene therapy
Europe
Zynteglo
Flag link:
bluebird bio Prepares for Launch
bluebird bio Prepares for Launch
Motley Fool
Bluebird Bio
Zynteglo
beta-thalassemia
drug launches
Flag link:
Where Will bluebird bio Be in 1 Year?
Where Will bluebird bio Be in 1 Year?
Motley Fool
Bluebird Bio
bb2121
Zynteglo
Flag link:
What Bluebird Bio Gets Wrong In Pricing For Its $1.8 Million Drug
What Bluebird Bio Gets Wrong In Pricing For Its $1.8 Million Drug
Forbes
Bluebird Bio
gene therapy
drug pricing
Zynteglo
beta thalassemia
Flag link:
Bluebird delays gene therapy launch to 2020, citing manufacturing tweaks
Bluebird delays gene therapy launch to 2020, citing manufacturing tweaks
Biopharma Dive
Bluebird Bio
gene therapy
drug manufacturing
Zynteglo
Flag link:
bluebird offers installment payments for Zynteglo gene therapy
bluebird offers installment payments for Zynteglo gene therapy
Pharmaforum
Bluebird Bio
outcome-based pricing
drug pricing
gene therapy
Zynteglo
beta thalassemia
Flag link:
Is $1.8 Million for bluebird bio's New Gene Therapy Ridiculous?
Is $1.8 Million for bluebird bio's New Gene Therapy Ridiculous?
Motley Fool
Bluebird Bio
Zynteglo
drug pricing
beta thalassemia
Flag link:
Bluebird sets $1.8M price tag for blood-disease gene therapy
Bluebird sets $1.8M price tag for blood-disease gene therapy
Biopharma Dive
drug pricing
Bluebird Bio
Zynteglo
Europe
beta thalassemia
Flag link:
Patients, payers await pricing plans for bluebird's first approved gene therapy
Patients, payers await pricing plans for bluebird's first approved gene therapy
BioCentury
Bluebird Bio
gene therapy
Zynteglo
drug pricing
beta thalassemia
Flag link:
Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval
Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval
Xconomy
Bluebird Bio
gene therapy
Europe
Zynteglo
EMA
beta thalassemia
Flag link:
Bluebird's not looking to break speed records with its first gene therapy launch
Bluebird's not looking to break speed records with its first gene therapy launch
Fierce Pharma
Bluebird Bio
gene therapy
beta thalassemia
Zynteglo
drug launches
Flag link:
bluebird to rollout Zynteglo starting in Germany next half
bluebird to rollout Zynteglo starting in Germany next half
BioCentury
Bluebird Bio
beta thalassemia
Germany
Zynteglo
Flag link: